Parkinsons Disease

Parkinson's Disease, Volume 132 addresses new developments in the F33 study of this disease, highlighting how the lives of people with Parkinson’s have undergone dramatic changes in the last decade. New to this edition are chapters on the Hallmarks of clinical aspects PD throughout centuries, The motor syndrome of Parkinson disease, The non-motor features of Parkinson’s disease, The New Diagnostic Criteria for Parkinson's disease, Advances in the Clinical Differential diagnosis, Clinical assessments in PD : Scales and monitoring, Biomarkers of Parkinson’s disease: an Introduction, and the Genetics of Parkinson’s Disease: Genotype-Phenotype Correlations.

The topics discussed in this comprehensive series provide a clearer understanding of the prodromal stage, genetics, strategies, routes of treatment, and development of non-dopaminergic therapies in Parkinson's Disease, both medical and surgical.

1. Hallmarks of clinical aspects PD throughout centuries 2. The motor syndrome of Parkinson disease 3. The non-motor features of Parkinson’s disease 4. The New Diagnostic Criteria for Parkinson's disease 5. Advances in the Clinical Differential diagnosis 6. Clinical assessments in PD : Scales and monitoring 7. Biomarkers of Parkinson’s disease: an introduction 8. Genetics of Parkinson’s Disease: Genotype-Phenotype Correlations 9. Imaging in pd 10. Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson’s Disease 11. Hallmarks of treatment aspects – Parkinson’s Disease throughout centuries including L-dopa 12.  Treatment strategies in early Parkinson's Disease 13. Treatment of non-motor symptoms in Parkinson’s disease 14.  Treatment of older Parkinson's Disease 15. New symptomatic treatments for the management of motor and non-motor symptoms of Parkinson’s disease 16. Device-aided treatment strategies in advanced Parkinson’s disease 17. Palliative care for patients and families with Parkinson’s disease 18. Multidisciplinary Care in Parkinson’s disease